Olympus Corporation A.I CyberSecurity Scoring
13/09/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Olympus Corporation in 2026.
No incidents recorded for Olympus Corporation in 2026.
No incidents recorded for Olympus Corporation in 2026.
Medical Equipment Manufacturing
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com. See community guidelines here: bit.ly/4vTpKjz
Latest updates, reports, and threat intel affecting the global network.
The cyber security unit boasts a revenue growth of more than 3x over the last five years, but analysts say it's still loss-making.
The group overhauled its internal security policies and named a board-level subcommittee as part of its ongoing attack recovery.
Olympus suffered a second cyber attack on their Americas operation a month after a suspected ransomware incident shut down its EMEA networks...
The Macaw malware is linked to the U.S.-sanctioned Evil Corp.
Researchers linked the incident that disrupted weekend broadcasts to Evil Corp., which used a ransomware strain associated with...
Japanese technology giant Olympus has confirmed it was hit by a cyberattack over the weekend that forced it to shut down its IT systems in the US, Canada and...
Olympus Corporation, the Japan-based manufacturer of optical and digital camera equipment, has announced that they are investigating a...
MorganFranklin Consulting, a Washington, DC area–headquartered management and technology advisory firm, has acquired the Microsoft...
This demanded a cross-industry summit—so now medical, security pros attend CyberMed.
Horilla is an HR and CRM software. Prior to 2.0.0, HorillaListView.export_data in horilla_views/generic/cbv/views.py accepts an authenticated user's columns POST parameter, takes field_tuple[1], interpolates it into dynamic_fn_str as Python source, and passes the generated function definition to exec(). A crafted string that remains valid under ast.literal_eval can inject Python syntax into a default argument evaluated during function definition, allowing arbitrary operating-system commands to execute with the application process privileges, including root privileges in the shipped Docker image. This issue is fixed in version 2.0.0.
Horilla is an HR and CRM software. Prior to 2.0.0, approve_validate_attendance_request at /attendance/approve-validate-attendance-request/ changes attendance_validated, is_validate_request_approved, approved_by, and related pending-request state through an HTTP GET before calling attendance.save(), so Django does not require CSRF validation for the action. An unauthenticated attacker can cause a logged-in manager with attendance.change_attendance to make a top-level request that carries the manager's SameSite=Lax session cookie, silently approving attendance with the victim's privileges and attributing the approval to the victim in the audit trail. This issue is fixed in version 2.0.0.
Actual is a local-first personal finance tool. Prior to 26.7.0, Actual Sync Server's CORS proxy is intended to let authenticated users fetch resources only from repositories listed in the official plugin allowlist. When `ACTUAL_GITHUB_TOKEN` is configured, the proxy automatically attaches the server's GitHub token to GitHub requests. The GitHub API allowlist check uses a raw `startsWith()` prefix test for `/repos/{owner}/{repo}` without requiring a path boundary after the repository name. If an allowlisted public plugin repository is `https://github.com/acme/plugin`, the proxy also accepts GitHub API URLs. Those URLs are outside the allowlisted repository but still pass because their API path starts with `/repos/acme/plugin`. The proxy then forwards the request with the server's `ACTUAL_GITHUB_TOKEN`, allowing any authenticated Actual user to read private GitHub resources reachable by that token. Version 26.7.0 fixes the issue.
The convert.base64-encode, convert.quoted-printable-encode and convert.quoted-printable-decode stream filters accept a line-break-chars option whose length is tracked separately from the string itself. The filter constructors duplicate the value with pestrdup(), which stops at the first NUL byte, while keeping the original length. When the filter later emits a line break it copies the recorded length out of the truncated allocation, reading past its end and placing adjacent heap bytes into the filter output.
The IPv6 branch of the FastCGI client access check compares only the first 12 bytes of a 16-byte IPv6 address, so listen.allowed_clients matches on a /96 prefix instead of the exact address. An attacker who can source an address sharing the first 96 bits with an allowed one passes the check and reaches the FastCGI endpoint.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.